PA

Your Article Summary

See Latest Articles

Is severe epistaxis associated with acetylsalicylic acid intake
The Laryngoscope, 11/03/09

Soyka MB et al. – The authors not only identified ASA to be one of the major risk factors in epistaxis, but also quantified its impact on the severity of nose bleeding. We emphasize the importance of a well–indicated antiaggregational therapy, and strongly discourage using ASA as a life–style drug for the elderly. ASA therapy needs to be discontinued whenever possible and reasonable.

Related Articles

See all related articles

Characterization of initial clinical symptoms and risk factors for sinonasal adenocarcinomas: results of a case-control study
International Archives of Occupational & Environmental Health, 11/06/09    Relevance Score: 80%

Dose finding and early efficacy study of gemcitabine plus capecitabine in combination with bevacizumab plus erlotinib in advanced pancreatic cancer
Journal of Clinical Oncology, 11/03/09    Relevance Score: 77%

Endovascular embolization with a vascular plug corrects a PAVM
JAAPA, 10/26/09    Relevance Score: 77%

Today in ENT...keeping you current

Receive free subspecialty "5-minute updates" via email

Surgical Outcome in Patients with Oral Verrucous Carcinoma: Long-Term Follow-Up in an Endemic Betel Quid Chewing Area
Journal for Oto-Rhino-Laryngology, 12/18/09

Correlation between subjective and objective evaluation of the nasal airway. A systematic review of the highest level of evidence
Clinical Otolaryngology, 12/18/09

Patterns of hearing loss in tympanic membrane perforation resulting from physical blow to the ear: a prospective controlled cohort study
Clinical Otolaryngology, 12/18/09

 See all of ENT